Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab

E.S.G. Stroes, D.M. Colquhoun, D.R. Sullivan, F. Civeira, R.S. Rosenson, Gerald Watts, E. Bruckert, L. Cho, R.E. Dent, B. Knusel, A. Xue, R.A.H. Scott, S.M. Wasserman, M.B. Rocco

Research output: Contribution to journalArticlepeer-review

443 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences

Chemistry